黑龙江医学2024,Vol.48Issue(10) :1272-1274.DOI:10.3969/j.issn.1004-5775.2024.10.037

血清DKK1在肝细胞癌诊疗中的应用研究进展

Recent Progress on the Application of Serum DKK1 in the Diagnosis and Treatment of Hepatocellular Carcinoma

宗绍其 郭冰洁 殷子斐
黑龙江医学2024,Vol.48Issue(10) :1272-1274.DOI:10.3969/j.issn.1004-5775.2024.10.037

血清DKK1在肝细胞癌诊疗中的应用研究进展

Recent Progress on the Application of Serum DKK1 in the Diagnosis and Treatment of Hepatocellular Carcinoma

宗绍其 1郭冰洁 2殷子斐3
扫码查看

作者信息

  • 1. 海军军医大学附属长海医院中医肿瘤科,上海 200433;上海中医药大学附属岳阳中西医结合医院肿瘤二科,上海 200437
  • 2. 上海中医药大学附属岳阳中西医结合医院消化科,上海 200437;海军军医大学中医系,上海 200433
  • 3. 海军军医大学附属长海医院中医肿瘤科,上海 200433;海军军医大学中医系,上海 200433
  • 折叠

摘要

肝细胞癌(HCC)是临床常见的恶性肿瘤,正确的早期诊断、科学的疗效判断在HCC癌的诊治中具有重要作用.近年来越来越多的研究证实,分泌性蛋白DKK1与HCC发生发展密切相关.血清DKK1作为一种简单易行的检测方法,在HCC诊疗中的应用价值日趋凸显.本文近年来国内外关于使用血清DKK1进行HCC诊断和鉴别诊断、病情评估和判断、治疗疗效分析等三方面的研究文献进行系统整理,供同行参考借鉴.

Abstract

Hepatocellular carcinoma is a common malignant tumor.Early diagnosis and accurate outcome evaluation are of vital importance in the diagnosis and treatment of hepatocellular carcinoma.In recent years,more and more studies have confirmed that the secretory protein DKK1 is closely related to the occurrence and development of hepatocellular carcinoma.Serum DKK1 analysis,as a simple and easy detection method,is becoming more and more important.The recent progress on the application of serum DKK1 in hepatocellular carcinoma has been summarized:diagnosis and differential diagnosis,disease assessment and outcome evaluation,so as to provide reference for peer researchers.

关键词

肝细胞癌/DKK1/血清/诊断/治疗

Key words

Hepatocellular carcinoma/DKK1/Serum/Diagnosis/Treatment

引用本文复制引用

基金项目

国家自然科学基金(81803929)

上海市自然科学基金(21ZR1479500)

出版年

2024
黑龙江医学
中华医学会黑龙江分会

黑龙江医学

影响因子:0.714
ISSN:1004-5775
参考文献量26
段落导航相关论文